» Articles » PMID: 21862983

The Microbiome and Rheumatoid Arthritis

Overview
Specialty Rheumatology
Date 2011 Aug 25
PMID 21862983
Citations 227
Authors
Affiliations
Soon will be listed here.
Abstract

Humans are not (and have never been) alone. From the moment we are born, millions of micro-organisms populate our bodies and coexist with us rather peacefully for the rest of our lives. This microbiome represents the totality of micro-organisms (and their genomes) that we necessarily acquire from the environment. Micro-organisms living in or on us have evolved to extract the energy they require to survive, and in exchange they support the physiological, metabolic and immune capacities that have contributed to our evolutionary success. Although currently categorized as an autoimmune disorder and regarded as a complex genetic disease, the ultimate cause of rheumatoid arthritis (RA) remains elusive. It seems that interplay between predisposing genetic factors and environmental triggers is required for disease manifestation. New insights from DNA sequence-based analyses of gut microbial communities and a renewed interest in mucosal immunology suggest that the microbiome represents an important environmental factor that can influence autoimmune disease manifestation. This Review summarizes the historical clues that suggest a possible role for the microbiota in the pathogenesis of RA, and will focus on new technologies that might provide scientific evidence to support this hypothesis.

Citing Articles

Gut microbiome synthesizes important core metabolites to prevent cognitive decline and mitigate onset and progression of Alzheimer's disease.

Al-Abbas N, Shaer N J Alzheimers Dis Rep. 2025; 8(1):1705-1721.

PMID: 40034366 PMC: 11863740. DOI: 10.1177/25424823241309024.


EasyMetagenome: A user-friendly and flexible pipeline for shotgun metagenomic analysis in microbiome research.

Bai D, Chen T, Xun J, Ma C, Luo H, Yang H Imeta. 2025; 4(1):e70001.

PMID: 40027489 PMC: 11865343. DOI: 10.1002/imt2.70001.


Gut microbiota dysbiosis and associated immune response in systemic lupus erythematosus: impact of disease and treatment.

Ali A, Zahran S, Eissa M, Kashef M, Ali A Gut Pathog. 2025; 17(1):10.

PMID: 39966979 PMC: 11834511. DOI: 10.1186/s13099-025-00683-7.


Disruption of Gut Microbiota and Associated Fecal Metabolites in Collagen-Induced Arthritis Mice During the Early Stage.

Wu D, Yin M, Cao D, Zhang X, Zhu Y, Wei Y J Inflamm Res. 2025; 18:1703-1717.

PMID: 39925933 PMC: 11806705. DOI: 10.2147/JIR.S502980.


Predicting host health status through an integrated machine learning framework: insights from healthy gut microbiome aging trajectory.

Bao Z, Yang Z, Sun R, Chen G, Meng R, Wu W Sci Rep. 2024; 14(1):31143.

PMID: 39732755 PMC: 11682237. DOI: 10.1038/s41598-024-82418-3.


References
1.
Xavier R, Podolsky D . Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007; 448(7152):427-34. DOI: 10.1038/nature06005. View

2.
Tilley B, Alarcon G, Heyse S, Trentham D, Neuner R, Kaplan D . Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group. Ann Intern Med. 1995; 122(2):81-9. DOI: 10.7326/0003-4819-122-2-199501150-00001. View

3.
Huse S, Dethlefsen L, Huber J, Welch D, Relman D, Sogin M . Exploring microbial diversity and taxonomy using SSU rRNA hypervariable tag sequencing. PLoS Genet. 2008; 4(11):e1000255. PMC: 2577301. DOI: 10.1371/journal.pgen.1000255. View

4.
LEDERBERG J . Infectious history. Science. 2000; 288(5464):287-93. DOI: 10.1126/science.288.5464.287. View

5.
Zorab P . The historical and prehistorical background of ankylosing spondylitis. Proc R Soc Med. 1961; 54:415-20. PMC: 1869548. View